Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals.

Other author Center for Drug Evaluation and Research (U.S.)
Other author International Conference on Harmonisation.
Format Electronic
Publication Info[Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 2008]
Descriptioniii, 20 p. : digital, PDF file
Supplemental Contenthttps://purl.fdlp.gov/GPO/LPS111169
Subjects

Portion of title Nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals
General noteTitle from PDF title page (viewed on Apr. 9, 2008).
General note"ICH harmonised tripartate guideline."
General note"M3(R2)."
General note"Current step 2 version dated 15 July, 2008."
General noteIncludes bibliographical references (p. 19-20).
General noteGPO Cataloging Record Distribution Program (CRDP).
Technical detailsMode of access: Internet at the FDA CBER Web site. Address as of 4/09/09: http://www.fda.gov/cder/guidance/8500dft.pdf ; current access is available via PURL.
GPO item number0499-T-02 (online)
Govt. docs number HE 20.4802:N 73

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available